Kotak Manufacture in India Fund
The scheme seeks to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme.
Growthvine rating: 5/5 — ranked #15 of 179 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹22.46 (as of 2026-08-21) |
|---|
| AUM | ₹2,951 Cr |
|---|
| Expense ratio | 1.68% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Harsha Upadhyaya |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| Sharpe ratio | 0.77 |
|---|
| Standard deviation | 16.99% |
|---|
| Max drawdown | -22.75% |
|---|
| Alpha | 5.38 |
|---|
| Beta | 0.97 |
|---|
Over 5 years, captured 91.7% of NIFTY India Manufacturing's upside and 84.3% of its downside.
Market cap allocation
| Large cap | 45.4% |
|---|
| Mid cap | 22.8% |
|---|
| Small cap | 31.8% |
|---|
Concentration
| Top 5 holdings | 20.6% |
|---|
| Top 10 holdings | 35.8% |
|---|
| Total holdings | 58 |
|---|
Top holdings
- Sun Pharmaceutical Industries Ltd. — 4.7%
- Mahindra & Mahindra Ltd. — 4.3%
- RUBICON RESEARCH LIMITED — 4.2%
- TATA STEEL LIMITED — 3.7%
- TVS Motor Company Ltd. — 3.7%
- Reliance Industries Ltd — 3.3%
- Maruti Suzuki India Ltd. — 3.1%
- DEE DEVELOPMENT ENGINEERS LIMITED — 3.1%
- Hero MotoCorp Limited — 2.9%
- Divis Laboratories Ltd. — 2.7%
Top sectors
- Automobile — 21.6%
- Industrial Products — 18.5%
- Pharma & Biotech — 16.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 13.6% | Q1 (Top) | #27 of 167 |
| 2025 | 7.5% | Q2 | #35 of 132 |
| 2024 | 25.9% | Q1 (Top) | #17 of 86 |
| 2023 | 32.2% | Q2 | #25 of 66 |